​​​​​PEER REVIEWED ARTICLES AND BOOK CHAPTERS

• Eastham JA, DiBlasio CJ, Scardino PT. Salvage radical prostatectomy for recurrence of prostate cancer after radiation therapy. Curr Urol Rep. 4(3), 211-215, 2003.

• Cho D, Di Blasio CJ, Rhee AC, Kattan MW. Prognostic factors for survival in patients with hormone-refractory prostate cancer (HRPC) after initial androgen-deprivation therapy (ADT). Urol Oncol. 21 (4), 282-91, 2003.

• Rhee AC, DiBlasio CJ, Cho D, Kattan MW. Predictive outcomes: Artificial neural networks (ANN) and nomograms. In: Klein, EA. Managing Prostate Cancer, 2nd ed., Humana Press, 2003.

• Di Blasio CJ, Rhee A, Cho D, Scardino PT, Kattan MW. Predicting clinical end points: Treatment nomograms in prostate cancer. Seminar Oncol. 30 (5), 567-86, 2003.

• DiBlasio CJ, Kattan MW. The use of nomograms to predict patients for risk of recurrence after definitive local therapy for prostate cancer. Urology. 62 (1), 9-18, 2003.

• DiBlasio CJ, Snyder ME, Kattan MW, Russo P. Ketorolac: safe and effective analgesia for the management of renal cortical tumors with partial nephrectomy. J Urol. 171 (3), 1062-1065, 2004.

• Slawin KM, DiBlasio CJ, Kattan MW. Minimally invasive therapy for prostate cancer: use of nomograms to counsel patients about the choice and probable outcome of therapy. Reviews in Urology. 6(4), 3-8, 2004.

• Kondabolu S, Khan SA, Whyard J, DiBlasio C, Ayyala M, Pentyala S. The role of endoluminal ultrasonography in urology: current perspectives. Int. Braz J Urol. 30(2), 96-101, 2004.

• Weiss JP, Blaivas JG, Tash Anger JA, Di Blasio CJ, Panagopoulos G, Gerboc J. Development and validation of a new treatment outcomes score for men with lower urinary tract symptoms (LUTS). Neurourol Urodyn. 23(2), 88-93, 2004.

• Stephenson AJ, Scardino PT, Bianco FJ Jr, DiBlasio CJ, Fearn PA, Eastham JA. Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy. J Urol. 172 (6 Pt 1), 2239-2243, 2004.

• Zahalsky M, Wilson SR, Di Blasio CJ, Lam SK, Nagler HM. Male Infertility on the internet: an analysis of web-based resources. BJU Int. 95(4), 481-484, 2005.

• Mallah KN, DiBlasio CJ, Rhee AC, Scardino PT, Kattan MW. Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy. Cancer. 2005 May 15;103(10):2030-4.

• Bianco FJ Jr, Scardino PT, Stephenson AJ, DiBlasio CJ, Fearn PA, Eastham JA. Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):448-53.

• Stephenson AJ, Scardino PT, Eastham JA, Bianco Jr. FJ, Dotan ZA, DiBlasio CJ, Reuther A, Klein EA, Kattan MW. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J. Clin Oncol. 2005 Oct 1; 23 (28): 7005-12.

• DiBlasio CJ, Snyder M, Russo P. Mini flank supra-eleventh rib incision: applying minimally-invasive principles to open partial or radical nephrectomy. BJU Int. 2006 Jan;97(1):149-56.

• Masterson TA, Bianco FJ Jr, Vickers AJ, DiBlasio CJ, Fearn PA, Rabbani F, Eastham JA, Scardino PT. The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer. J Urol. 2006 Apr;175(4): 1320-1325.

• Malcolm JB, Derweesh IH, Kincade MC, DiBlasio CJ, Lamar KD, Wake RW, Patterson AL. Incidence of osteoporosis and skeletal fractures in men undergoing androgen deprivation therapy for prostate cancer. Can J Urol. 2007 Jun;14(3):3551-9.

• Derweesh IH, DiBlasio CJ, Malcolm J, Kincade MC, Lamar KD, Patterson AL, Kitabchi AE, Wake RW. Risk of new-onset diabetes mellitus and worsening glycemic parameters for established diabetes in men undergoing androgen deprivation therapy for prostate cancer. BJU Int. 2007 Nov;100(5):1060-5.

• DiBlasio CJ, Malcolm JB, Womack JH, Kincade MC, Mancini J, Ogles M, Lamar, KD, Derweesh IH, Patterson AL, Wake RW. Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer. BJU Int. 2008 Jul;102(1):39-43.

• Malcolm JB, Derweesh IH, Brightbill KE, Mehrazin R, DiBlasio CJ, and Wake RW. Efficacy of tubeless percutaneous nephrolithotomy for complex renal stone disease: Single center experience. Can J Urol. 2008 Jun;15(3):4072-7.

• Derweesh IH, Malcolm JB, DiBlasio CJ, Mehrazin R, Jackson S. Sutureless laparoscopic heminephrectomy: Safety and efficacy in physiologic and chronically obstructed porcine kidney. Surg Innov. 2008 Sep;15(3):194-202.

• Malcolm JB, Derweesh IH, Mehrazin R, DiBlasio CJ, Vance DD, Joshi S, Gold R, Wake RW. Nonoperative management of blunt renal trauma: Is routine early follow-up imaging necessary? BMC Urology, 2008, 8:11.

• DiBlasio CJ, Derweesh IH, Malcolm JB, Maddox MM, Aleman MA, Patterson AL, Wake RW. Contemporary analysis of erectile, voiding, and oncologic outcomes following primary targeted cryoablation of the prostate for clinically localized prostate cancer. Intl Braz J Urol. 2008 Jul-Aug;34(4):443-50.

• DiBlasio CJ, Hammett J, Malcolm JB, Womack JH, Kincade MC, Mancini J, Ogles M, Lamar KD, Derweesh IH, Patterson AL, Wake RW. Patterns of diagnosis and predictive factors for development of psychiatric illness in patients receiving androgen deprivation therapy for prostate cancer. Canadian J Urol. 2008 Oct;15(5):4249-56.

• Nelson CJ, DiBlasio C, Kendirci M, Hellstrom W, Guhring P, Mulhall JP. The chronology of depression and distress in men with Peyronie's Disease. J. Sexual Med., 2008 Aug;5(8):1985-90.

• Derweesh IH, Malcolm JB, DiBlasio CJ, Giem A, Rewcastle JC, Wake RW, Patterson AL and Gold R. Single center comparison of laparoscopic cryoablation and CT-guided percutaneous cryoablation for renal tumors. J Endourol., 2008 Nov; 22(11):2461-7.

• Bagrodia A, DiBlasio CJ, Wake RW, Derweesh IH. Adverse effects of androgen deprivation therapy in prostate cancer: current management issues. Indian J Urol., 2009 April; 25(2): 169-76.

• DiBlasio CJ, Malcolm JB, Hammett J, Wan JY, Aleman MA, Patterson AL, Wake RW, Derweesh IH. Survival outcomes in men receiving androgen deprivation therapy as primary or salvage treatment for localized or advanced prostate cancer: 20-year single-center experience. BJU Int., 2009 November; 104(9): 1208-14.

• Malcolm JB, Bagrodia A, Derweesh IH, Mehrazin R, DiBlasio CJ, Wake RW, Wan JY, Patterson AL. Comparison of rates and risk factors for developing chronic renal insufficiency, proteinuria, and metabolic acidosis after radical and partial nephrectomy. BJU Int., 2009 August; 104(4): 476-81.

• DiBlasio CJ, Kurta J, Botta S, Malcolm JB, Wan JY, Derweesh IH, Aleman MA, Wake RW. Peyronie’s disease has a negative impact on the durability and component malfunction rates in patients undergoing inflatable penile prosthesis implantation. BJU Int., 2010 September; 106(5): 691-4.

• Bagrodia A, Mehrazin R, Malcolm JB, DiBlasio CJ, Wan JY, Patterson AL, Wake RW, Derweesh IH. Comparison of rates and risk factors for development of chronic renal insufficiency, proteinuria, and metabolic acidosis following radial or partial nephrectomy. BJU Int., 2009 August; 104(4): 476-81.

• Mehrazin R, Derweesh I, Giem A, Balazs L, DiBlasio C. Local excision of fibroma of the testicular tunic in a HIV patient. Curr Urol., 2009; 3: 158-60.

• DiBlasio CJ, Kurta J, Botta S, Mehrazin R, Brahmbhatt J, Wan JY, Derweesh IH, Aleman MA, Patterson AL, Wake RW. Peyronie’s disease has a negative impact on the durability and component malfunction rates in patients undergoing inflatable penile prosthesis implantation. BJU Int., Sept. 2010; 106(5):691-4.

• Bagrodia A, Mehrazin R, DiBlasio CJ, Malcolm JB, Wake RW, Patterson AL, Wan JY, Derweesh IH. Variation in the incidence of and risk factors for development of nephrolithiasis after radical or partial nephrectomy. BJU Int., Oct. 2010;106(8): 1200-4.

• Silberstein JL, Millard F, Mehrazin R, Kopp R, Bazzi W, DiBlasio CJ, Patterson AL, Downs TM, Yunus F, Kane CJ, Derweesh IH. Feasibility and efficacy of neoadjuvant sunitinib before nephron-sparing surgery. BJU Int., Nov. 2010; 106(9): 1270-6.

• DiBlasio CJ, Maddox M, Mehrazin R, Malcolm JB, Yu C, Aleman MA, Derweesh IH, Patterson AL, Wake RW, Kattan MW. Nomogram to predict prostate cancer diagnosis on transrectal ultrasound-guided prostate biopsy in a contemporary series. Curr Urol., Dec. 2012, 6 (3); 141-145.

• Ward J, DiBlasio CJ, Williams C, Givens R, Jones S. Cryoablation for locally advanced clinical stage T3 prostate cancer: a report from the Cryo-On-Line Database (COLD) Registry. BJU Int., Sept. 2013 (Epub ahead of print).